What is it?
Policosanol is a supplement used to treat heart disease and Parkinson's disease. It is also used to decrease cholesterol (fat) in the blood.
Other names for Policosanol include: Octacosanol
Ask your doctor, nurse, or pharmacist if you need more information about this medicine or if any information in this leaflet concerns you.
Tell your doctor if you
Talk with your caregiver about how much Policosanol you should take. The amount depends on the strength of the medicine and the reason you are taking Policosanol. If you are using this medicine without instructions from your caregiver, follow the directions on the medicine bottle. Do not take more medicine or take it more often than the directions tell you to.
To store this medicine:
Keep all medicine locked up and away from children. Store medicine away from heat and direct light. Do not store your medicine in the bathroom, near the kitchen sink, or in other damp places. Heat or moisture may cause the medicine to break down and not work the way it should work. Throw away medicine that is out of date or that you do not need. Never share your medicine with others.
Stop taking your medicine right away and talk to your doctor if you have any of the following side effects. Your medicine may be causing these symptoms which may mean you are allergic to it.
Other Side Effects:
You may have the following side effects, but this medicine may also cause other side effects. Tell your doctor if you have side effects that you think are caused by this medicine.
1. Arruzazabala ML, Molina V, Carbajal D et al: Effect of policosanol on platelet aggregation in type II hypercholesterolemic patients. Tissue Reactions 1998; 20(4):119-124.
2. Stusser R, Batista J, Padron B et al: Long-term therapy with policosanol improves treadmill exercise-ECG testing performance of coronary heart disease patients. Int J Clin Pharmacol Ther 1998; 36(9):469-473.
3. Valdes S, Arruzazabala ML, Fernandez L et al: Effect of policosanol on platelet aggregation in healthy volunteers. Int J Clin Pharmacol Res 1996; 16(2-3):67-72.
4. Batista J, Stusser R, Saez F et al: Effect of policosanol on hyperlipidemia and coronary heart disease in middle-aged patients. A 14-month pilot study. Int J Clin Pharmacol Ther 1996; 34(3):134-137.
5. Castano G, Tula L, Canetti M et al: Effects of policosanol in hypertensive patients with type II hypercholesterolemia. Curr Ther Res 1996; 57(9):691-695.
6. Canetti M, Moreira M, Mas R et al: A two-year study on the efficacy and tolerability of policosanol in patients with type II hyperlipoproteinaemia. Int J Clin Pharmacol Res 1995; 15(4):159-165.
7. Castano G, Canetti M, Moreira M et al: Efficacy and tolerability of policosanol in elderly patients with type II hypercholesterolemia: A 12-month study. Curr Ther Res 1995; 56 (8):819-823.
8. Torres O, Agramonte AJ, Illnait J et al: Treatment of hypercholesterolemia in NIDDM with policosanol. Diabetes Care 1995; 18(3):393-397.
9. Snider SR: Octacosanol in Parkinsonism. Ann Neurol 1984; 6(6):723.
10.Arruzazabala ML, Carbajal D, Mas R et al: Effects of policosanol on platelet aggregation in rats. Thrombosis Res 1993; 69(3):321-327.
11.Pons P, Rodriquez M, Robaina C et al: Effects of successive dose increases of policosanol on the lipid profile of patients with type II hypercholesterolaemia and tolerability to treatment. Int J Clin Pharmacol Res 1994; 14(1):27-33.
Last Updated: 4/4/2014
Copyright © 1984- Thomson Micromedex. All rights reserved.